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The proteasome plays an important role in proteosta-
sis by carrying out controlled protein degradation in
the cell. Impairments in proteasome function are
associated with severe and often age-related dis-
eases. Here, we have characterized a molecular
mechanism linking insulin/IGF-1 signaling (IIS) to pro-
teasome activity. We show that decreased IIS, which
promotes proteostasis and longevity, increases pro-
teasome activity through the FOXO transcription fac-
tor DAF-16 in C. elegans. Furthermore, we reveal that
DAF-16 represses expression of the proteasome-
associated deubiquitinating enzyme ubh-4, which
wesuggest functionsasa tissue-specificproteasome
inhibitor. Finally, we demonstrate that proteasome
activation through downregulation of the ubh-4 hu-
man ortholog uchl5 increases degradation of proteo-
toxic proteins in mammalian cells. In conclusion, we
have established a mechanism by which the evolu-
tionarily conserved IIS contributes to the regulation
of proteasome activity in a multicellular organism.
INTRODUCTION
Maintenance of protein homeostasis is essential to all living or-
ganisms. As an important part of the proteostasis network, the
ubiquitin-proteasome system (UPS) executes most of the
controlled protein degradation in the cell. In the UPS, the sub-
strate protein targeted for degradation becomes polyubiquiti-
nated via the actions of the ubiquitin-activating E1 enzyme,
conjugating E2 enzymes, and ligating E3 enzymes (Hershko
and Ciechanover, 1998). The polyubiquitinated substrate is
then recognized and degraded by the 26S proteasome, a large
multisubunit protein complex consisting of a 20S core capped
by one or two regulatory 19S lid particles. The 20S core is a bar-
rel-shaped complex of 28 subunits (14 a and 14 b subunits), and
it contains the proteolytic activities of the proteasome, whereas
the 19S regulatory particle, responsible for capture, deubiquiti-
nation, and unfolding of the polyubiquitinated substrates, forms
from 19 different subunits. In addition, there are multiple protea-
some-associated proteins possessing essential activities, such1980 Cell Reports 3, 1980–1995, June 27, 2013 ª2013 The Authorsas ubiquitin ligases and deubiquitinating enzymes (DUBs), which
regulate proteasome function (Finley, 2009; Hanna and Finley,
2007). The 20S can also be activated by the 11S complexes
and PA200/Blm10 to promote degradation, probably mainly in
an ubiquitin-independent manner (Stadtmueller and Hill, 2011).
Thus, the proteasome is not a static proteolytic machine; on
the contrary, its function is highly regulated (Finley, 2009; Hanna
and Finley, 2007). However, it remains an open question how
proteasome activity is regulated in a multicellular organism.
Dysfunction of the proteasome has been detected in many se-
vere disorders, such as Alzheimer’s, Parkinson’s, and Hunting-
ton’s diseases (Dahlmann, 2007), which usually emerge at the
later stages of life. Accordingly, it has been postulated mainly
based on in vitro proteasome activity assays that proteasomal
degradation decreases upon aging. This might be due to
reduced expression of proteasome subunits, a decrease in pro-
teasome assembly, modifications of proteasome subunits, and/
or inhibitory effects of oxidized and crosslinked substrates (Ver-
nace et al., 2007). Additionally, the association and function of
different proteasome regulators might change upon aging. Inter-
estingly, an inhibitory mechanism seems to be part of the protea-
some regulation and not only a physiological effect caused by
aging, as the proteasome-associated DUB USP14 and its yeast
ortholog Ubp6 have been shown to inhibit the proteasome
(Hanna et al., 2006; Lee et al., 2010).
We have previously shown that proteasome activity changes
upon aging in C. elegans (Hamer et al., 2010). This led us to
ask whether signaling pathways regulating longevity also affect
proteasome activity. Insulin/IGF-1 signaling (IIS) is an evolution-
arily conserved signaling cascade regulating lifespan in worms,
flies, rodents, and possibly humans (Kenyon, 2005, 2010). In
C. elegans, reduced IIS caused by mutations in DAF-2 (insulin/
IGF-1 receptor ortholog) leads to long-lived and stress-resistant
worms (Kenyon et al., 1993), mediated through negative regula-
tion of the FOXO transcription factor DAF-16 (Lin et al., 1997,
2001; Ogg et al., 1997). DAF-16 controls expression of multiple
genes regulating diverse processes such as metabolism, stress
responses, longevity, and development (Lee et al., 2003; Murphy
et al., 2003). Decreased IIS also affects protein homeostasis dur-
ing the normal aging process (Ben-Zvi et al., 2009; David et al.,
2010) and under disease-related conditions (Cohen et al.,
2006, 2009; Hsu et al., 2003; Morley et al., 2002).
In the current study, we demonstrate that proteasome activity
is modified through the IIS and the proteasome-associated DUB
UBH-4. Our data show that DAF-16 negatively affects ubh-4
expression. In line with being one of the many DAF-16 targets
genes, our data reveal that ubh-4 has a mild effect on
C. elegans longevity. Furthermore, our results demonstrate that
knockdown of uchl5, the mammalian ortholog of ubh-4, leads
to increased degradation of proteins linked to proteotoxicity.
Hence, we have established a molecular mechanism connecting
the evolutionarily conserved IIS pathway to DUB-regulated pro-
teasome activity.
RESULTS
IIS-Deficient daf-2 Mutants Display Higher UPS Activity
than Wild-Type Animals
Aging causes a decline in protein homeostasis leading to accu-
mulation of damaged and unfolded proteins. An increasing body
of evidence suggests that the same signaling pathways that are
involved in controlling aging, including IIS, also regulate the me-
diators of proteostasis, such as metabolic enzymes, stress pro-
teins, and chaperones (Balch et al., 2008). Here, we investigate
whether IIS also contributes to regulation of the UPS by using
thewell-established agingmodelC. elegans. We have previously
developed an in vivo reporter system for UPS activity based on
the photoconvertible UbG76V-Dendra2 reporter protein (Hamer
et al., 2010; Li et al., 2011), which allows us tomeasure the rate of
proteasomal degradation in live animals. Because the intestine is
an important tissue for DAF-16-mediated longevity in C. elegans
(Libina et al., 2003), we initially imaged UPS activity in intestinal
cells. The photoconverted UbG76V-Dendra2 signal decreased
by approximately 30% in 6 hr in wild-type animals compared
to an approximately 2-fold faster degradation in the long-lived
daf-2(e1370) mutants (Figures 1A and 1B; Tables S1 and S2)
without an effect on the control Dendra2 (Figures S1A and
S1B). RNAi against proteasome 19S subunit rpn-2 decreased
the degradation of UbG76V-Dendra2 in the intestine of daf-
2(e1370) mutants (Figure 1C), whereas RNAi of autophagy
component lgg-1 did not affect reporter degradation (Fig-
ure S1D), demonstrating that the reporter was proteasomally
degraded in these animals. The enhanced UPS activity detected
upon decreased IIS was DAF-16 dependent, as the effect was
diminished in the daf-16(m26);daf-2(e1370) double mutant
(Figures 1A and 1B). The short-lived daf-16(m26) or daf-
16(mgDf50)mutants, deficient in five or all eight DAF-16 isoforms
(Kwon et al., 2010; Lin et al., 1997; Ogg et al., 1997), showed
similar reporter degradation as wild-type animals (Figure 1B).
Together, these results demonstrate that under conditions of
reduced IIS, active DAF-16 is mediating the enhanced UPS ac-
tivity in the intestine.
We have previously shown that UPS reporter degradation is
relatively slow in body-wall muscle cells (Hamer et al., 2010),
and in line with this observation both the wild-type and daf-
2(e1370) animals showed similar UbG76V-Dendra2 degradation
of about 10% at 6 hr after photoconversion (data not shown).
However, in 24 hr body-wall muscle cells of the daf-2(e1370)mu-
tants exhibited a significantly faster UPS reporter degradation
(approximately 1.2-fold) compared to wild-type animals (Figures
1D and S1C), which was not dependent on autophagy (Fig-
ure S1E). In contrast to the degradation in intestinal cells, theCdaf-16(m26);daf-2(e1370) or daf-16(mgDf47);daf-2(e1370)
double mutations did not significantly decrease the reporter
degradation rate (Figure 1D), suggesting that the enhanced
degradation does not require active DAF-16 in body-wall muscle
cells. Interestingly, daf-16(m26)mutants (deficient in five DAF-16
isoforms) displayed similar reporter degradation in body-wall
muscle cells as the daf-2(e1370) mutants (Figure 1D). This ap-
peared to be a muscle-specific function of the DAF-16 isoforms,
because in daf-16(mgDf50) mutants (deficient in all DAF-16 iso-
forms) degradation was comparable to wild-type animals (Fig-
ure 1D). Altogether, reduced IIS leads to a minor increase in
UPS activity also in body-wall muscle cells, but in a DAF-16-in-
dependent manner.
The proteasomal degradation of the UbG76V-Dendra2 UPS
reporter is likely affected by specific ubiquitin ligase(s). There-
fore, we have developed a fluorescent reporter that responds
to changes in proteasome activity by detecting the pool of poly-
ubiquitinated proteins in vivo. The reporter takes advantage of a
commercially available short-lived fluorescent ZsProSensor
fusion protein, which consists of ZsGreen fused to the C-termi-
nal part of the mouse ornithine decarboxylase, a protein domain
mediating proteasomal degradation in an ubiquitin-independent
manner (Murakami et al., 1992). In line with being a proteasomal
substrate, expression of the ZsProSensor in intestinal cells did
not produce a fluorescent signal, suggesting that it is rapidly
degraded in C. elegans (data not shown). We hypothesized
that fusing the ZsProSensor to the ubiquitin interaction motifs
(UIMs) of the proteasome 19S subunit RPN-10 would create a
reporter that binds polyubiquitinated proteins via its UIM motifs,
resulting in stabilization of the reporter and detectable fluores-
cence. Approaches using the polyubiquitin-binding domains
have been reported for capturing the cellular pool of polyubiqui-
tin chains from mammalian cell lysates (Bennett et al., 2007) and
for visualizing polyubiquitinated proteins in mammalian cells
(Sims et al., 2012). Expression of our polyubiquitin reporter in
the C. elegans intestine resulted in visible fluorescent foci with
a colocalizing pattern to immunostained polyubiquitinated pro-
teins (Figure S2A). As we predicted, the polyubiquitin reporter
also responded to proteasome dysfunction, as RNAi against
rpn-2 generated 2.6-fold higher fluorescent signal compared
to control RNAi-treated animals (Figure S2B), thus validating
the function of this in vivo polyubiquitin reporter system. The
change in fluorescence intensity is likely dependent on both
the UIM domains and the ZsProSensor degron, as upon protea-
some impairment we would expect less degron-mediated
degradation of the reporter resulting in increased fluorescence,
as well as an increase in cellular polyubiquitinated proteins,
which would create more binding sites for the polyubiquitin re-
porter and result in increased reporter fluorescence. Thus, the
polyubiquitin reporter stability is affected by the balance be-
tween proteasomal degradation and binding to polyubiquiti-
nated proteins. By using the polyubiquitin reporter approach,
we were able to confirm the importance of DAF-16 in enhancing
proteasomal degradation in the intestine, as daf-16 RNAi
increased the fluorescent intensity in the daf-2(e1370) back-
ground, but not in wild-type animals (Figure 2). These results
further demonstrate that IIS has a crucial role in regulating pro-
teasome activity in vivo.ell Reports 3, 1980–1995, June 27, 2013 ª2013 The Authors 1981
Figure 1. Reduced IIS Increases UPS Activity In Vivo
(A) Fluorescencemicrographs of wild-type, daf-2(e1370), and daf-16(m26);daf-2(e1370) animals expressing UbG76V-Dendra2 in intestinal cells before, after, and
6 hr after photoconversion.
(B) Quantification of UbG76V-Dendra2 degradation in intestinal cells of wild-type and IIS mutant animals.
(C) Quantification of UbG76V-Dendra2 degradation in intestinal cells of daf-2(e1370) animals after control or rpn-2 RNAi.
(D) Quantification of UbG76V-Dendra2 degradation in body-wall muscle cells of wild-type and IIS mutant animals. All graphs show the average percentage of
green or red fluorescence relative to the initial fluorescence intensity (before photoconversion) or the intensity at the point of photoconversion (0 hr after con-
version), respectively.
Scale bar 20 mm. Error bars, SEM, *p < 0.05 and **p < 0.01, Table S2. See also Figure S1.
1982 Cell Reports 3, 1980–1995, June 27, 2013 ª2013 The Authors
Figure 2. IIS Affects the Stability of the In-
testinal Polyubiquitin Reporter
(A) Fluorescence micrographs of control or daf-16
RNAi-treated wild-type animals expressing
the polyubiquitin reporter (Pvha-6::UIM2-ZsPro-
Sensor) in the intestine.
(B) Quantification of the fluorescent intensity of the
intestinal polyubiquitin reporter in wild-type ani-
mals after control or daf-16 RNAi.
(C) Fluorescence micrographs of control or daf-16
RNAi-treated daf-2(e1370) animals expressing
the polyubiquitin reporter (Pvha-6::UIM2-ZsPro-
Sensor) in the intestine. Exposure time used
for green fluorescent channel is longer in (A) than
in (C).
(D) Quantification of the fluorescent intensity of the
intestinal polyubiquitin reporter in daf-2(1370) an-
imals after control or daf-16 RNAi. Graphs show
average fold change in fluorescence compared to
the control RNAi (set as 1). Error bars, SEM, **p <
0.01, Table S2.
See also Figure S2.To complement the in vivo approaches, we also investigated
proteasome activity in whole-animal lysates (Figure 3A) using
the well-known native in-gel proteasome activity assay with
suc-LLVY-AMC-substrate (Elsasser et al., 2005), which enables
visualization of active proteasome complexes. We observed that
daf-2(e1370) mutants displayed approximately 1.6-fold higher
proteasome activity compared to wild-type animals (Figure 3B),
which is similar to the in vivo UPS reporter data (Figures 1A and
1B). The increase in activity was diminished in daf-16(m26);daf-
2(e1370) double mutants (Figure 3B), further demonstrating that
activation of DAF-16 through decreased IIS enhances protea-
some activity. Proteasome activity was slightly increased in ly-
sates from daf-16(m26) mutants (Figure 3B), which parallels
the observation in body-wall muscle cells (Figure 1D) and show
that the in vitro assay reflects the sum of proteasome activity.
Taken together, both our in vivo and in vitro results demonstrate
that the reduced IIS in long-lived daf-2(e1370)mutants enhances
proteasome activity. Notably, a recent article (Vilchez et al.,
2012b) stated that reduced IIS does not upregulate proteasome
activity based on in vitro proteasome peptidase assay
with whole-animal lysates from the sterile daf-2(mu150);fer-
15(b26);fem-1(hc17) mutant strain. The differences in genetic
background of the daf-2 animals and in the specificity of the
in vitro assays used most likely explain the different outcome
compared to our study.Cell Reports 3, 1980–199Our observed increase in proteasome
activity in daf-2(e1370) mutants could
arise from differences in proteasome
abundance. However, no difference in
the proteasome amount was detected
between wild-type and IIS mutant ani-
mals by western blotting against the pro-
teasome 20S alpha subunits (Figures 3C
and 3D). Our result is in agreement with
previous microarray and quantitative
mass spectrometry data, showing thatproteasome subunits are notmore highly expressed in daf-2mu-
tants than in wild-type animals (Dong et al., 2007; McElwee et al.,
2003; Murphy et al., 2003; Zarse et al., 2012). Thus, the
enhanced UPS activity detected upon decreased IIS in
C. elegans is not derived from changes in proteasome levels,
but rather from differences in the regulation of its function.
UBH-4 Is a Proteasome-Associated DUB in C. elegans
We hypothesized that there might be differences in the com-
position of the proteasome regulatory complexes between
wild-type and daf-2(e1370) animals. We therefore analyzed
RP2-core particle (CP) and RP-CP complexes isolated from
native gel with LC-MS-MS and detected most of the 19S regula-
tory particles in both wild-type and daf-2(e1370) samples (Table
S3). Variations in 19S RP composition or in the associated pro-
teins may lead to differences in proteasome activity. Interest-
ingly, the deubiquitinating enzyme (DUB) UBH-4 was detectable
in wild-type, but not in daf-2(e1370) samples. UBH-4 has pre-
viously been shown to interact with the 19S subunit RPN-13 by
yeast two-hybrid experiment (Li et al., 2004) and the mammalian
homolog UCHL5 to associate with RPN13 (Hamazaki et al.,
2006; Qiu et al., 2006; Yao et al., 2006). To investigate the
in vivo interaction in C. elegans, we expressed His- and strepta-
vidin-binding-protein (SBP)-tagged UBH-4 and HA-tagged
RPN-13 under their own promoters. Immunoprecipitation of5, June 27, 2013 ª2013 The Authors 1983
Figure 3. Reduced IIS Increases Protea-
some Activity In Vitro without Affecting Pro-
teasome Amount
(A) Lysates of wild-type and IIS mutant animals
separated on a native gel followed by in-gel pro-
teasome activity assay with fluorogenic suc-LLVY-
AMC substrate. Lower panel shows Coomassie
staining of the gel. RP-CP and RP2-CP refer to
proteasome 20S CP capped at one or both ends
with 19S RP, respectively.
(B) Quantification of proteasome in-gel activity
from wild-type and IIS mutant animals. Graph
shows the average fold changes compared to the
wild-type (set as 1). The quantification is the sum of
fluorescent signal within RP2-CP, RP-CP, and CP.
Results are mean of quantifications of indepen-
dent experiments (N2 and daf-2[e1370] n = 21, daf-
16[m26] n = 17 and daf-16[m26];daf-2[e1370] n =
16). Error bars, SEM.
(C) Lysates of wild-type and IIS mutant animals
immunoblotted against proteasome 20S alpha
subunits.
(D) Quantification of the proteasome immunoblots.
Graph shows the average fold changes compared
to the wild-type (set as 1). Results are mean of
quantifications (n = 3 independent experiments for
all strains). Error bars, SEM.His-SBP-UBH-4, but not His-SBP-GFP, brought down HA-RPN-
13 (Figure 4A), demonstrating that UBH-4 and RPN-13 interact in
C. elegans.
To confirm the DUB function of UBH-4 inC. elegans, we down-
regulated UBH-4 by RNAi and analyzed the proteasome-associ-
ated DUB activity with in-gel activity assay. To specifically detect
the proteasome-associated DUB activity, only the part of the
native gel containing the RP2-CP and RP-CP complexes was
incubated with the Ub-AMC substrate. A clear reduction in fluo-
rescence, i.e., substrate hydrolysis, which reflects decreased
deubiquitinating activity, was detected in lysates of ubh-4
RNAi-treated animals compared to control lysates, establishing
that UBH-4 functions as a DUB in C. elegans (Figure 4B). Addi-
tionally, we observed accumulation of polyubiquitinated proteins
after ubh-4 RNAi (Figures 4C and 4D), suggesting that the deubi-
quitinating activity of UBH-4 is required to maintain protein
homeostasis.
Expression of ubh-4 Is Negatively Regulated by DAF-16
As we detected UBH-4 in lysates from wild-type, but not daf-
2(e1370) mutant animals in the mass spectrometry analysis,
we speculated that the expression of ubh-4 may be regulated
through IIS. To examine the transcriptional regulation of ubh-4,
we expressed GFP under the ubh-4 promoter and 30 UTR. GFP
was detected in several tissues such as the muscles and neu-1984 Cell Reports 3, 1980–1995, June 27, 2013 ª2013 The Authorsrons, with the highest expression being
in the intestine (Figure 5A). The ubh-4
expression decreased upon aging but
without notable changes in the ex-
pression pattern (Figures S3A and S3B).
Interestingly, a clear difference between
wild-type and daf-2(e1370) mutants wasa high GFP expression in the intestine of young adult wild-type
animals (Figure 5A, left panels), hardly detectable in the daf-
2(e1370) mutants (Figure 5A, middle left panels). In turn, daf-
2(e1370) mutants displayed higher GFP expression in embryos
than the wild-type animals (Figure 5A, middle left panels). daf-
16(m26) and daf-16(m26);daf-2(e1370) mutants showed similar
expression pattern as the wild-type animals with a strong GFP
signal in the intestine (Figure 5A, right middle and right panels,
respectively). Taken together, these data suggest that DAF-16
negatively regulates ubh-4 expression in the intestine. Because
different DAF-16 isoforms regulate expression of partly distinct
sets of genes (Kwon et al., 2010), we also investigated the
expression of Pubh-4::gfp in daf-16 deletion mutants in addition
to the daf-16(m26) point mutation. In both daf-16(mgDf50) and
daf-16(mgDf47);daf-2(e1370) deletion mutants, the GFP expres-
sion pattern resembled wild-type with high intestinal expression
(Figure S4A). To further confirm the DAF-16-dependent regula-
tion of ubh-4 expression in the intestine, we downregulated
DAF-16 by RNAi in daf-2(e1370) animals expressing Pubh-
4::gfp. daf-16 RNAi clearly increased the GFP signal in the intes-
tine of daf-2(e1370) mutants (Figure S4B), demonstrating that
ubh-4 expression is negatively regulated by DAF-16 in the
intestine of C. elegans. The DAF-16a and DAF-16d/f isoforms
have been connected to lifespan regulation (Kwon et al., 2010;
Lee et al., 2001; Lin et al., 2001), and we therefore performed
Figure 4. UBH-4 Interacts with RPN-13 and
Functions as a DUB in C. elegans
(A) Immunoprecipitation of HA-RPN-13 with His-
SBP-UBH-4 or His-SBP-GFP (control) fromwhole-
animal lysates followed by western blotting with
anti-HA and streptavidin-HRP antibodies. Black
arrow indicates His-SBP-UBH-4 and gray arrow
His-SBP-GFP band.
(B) Lysates of rrf-3(pk1426) animals treated with
control or ubh-4 RNAi separated on a native gel
followed by in-gel DUB activity assay. Only the
part of the native gel containing the RP2-CP and
RP-CP was incubated with the fluorogenic Ub-
AMC substrate. Note that the bands correspond-
ing to the RP2-CP and RP-CP tend to diffuse in the
native gel. Lower panel shows Coomassie staining
of the same gel piece.
(C) Lysates of rrf-3(pk1426) animals treated with
control or ubh-4 RNAi immunoblotted against
polyubiquitinated proteins.
(D) Quantification of polyubiquitinated protein
amount. Graph shows the average fold change
compared to the control RNAi (set as 1). Results
are mean of quantifications (control and ubh-4
RNAi n = 14 independent experiments). Error bars,
SEM.DAF-16 isoform-specific RNAi. Both downregulation of daf-16a
and daf-16d/f induced an upregulation of Pubh-4::gfp expres-
sion in the intestine of daf-2(e1370) mutants (Figure S4C), sug-
gesting that multiple DAF-16 isoforms are regulating ubh-4
expression. We identified one canonical DAF-16 binding site
(GTAAACA, Furuyama et al., 2000) on the proximal promoter
(531–525 bp upstream from first coding codon) of ubh-4. This
site is also contained within the modENCODE reported DAF-16
binding region defined by chromatin immunoprecipitation
sequencing (ChIP-seq) of a DAF-16::GFP fusion protein (Celniker
et al., 2009) (Figure S4D). We mutated the canonical DAF-16
binding site on Pubh-4::gfp expression vector and observed a
clear increase in intestinal GFP expression in daf-1(e1370) ani-
mals (Figure 5B), suggesting that DAF-16 regulates ubh-4
expression from its canonical binding site on the ubh-4
promoter.
The overall ubh-4 expression was downregulated by 20% in
daf-2(e1370) mutants compared to wild-type animals when
analyzed by quantitative PCR (qPCR) (Figure 5C). However,
daf-16(m26) and daf-16(m26);daf-2(e1370) double mutants
showed similar levels of ubh-4mRNA compared to wild-type an-
imals (Figure 5C), providing further support for the observation
that DAF-16 negatively regulates ubh-4 expression. To test
whether we could mimic the ubh-4 expression level detected
in daf-2(e1370) mutants, we performed ubh-4 RNAi dilution ex-Cell Reports 3, 1980–199periments. ubh-4 RNAi produced an
approximately 80% decrease in ubh-4
mRNA levels (Figure 5D). By diluting
ubh-4 RNAi bacteria to a final concentra-
tion of 1% with bacteria carrying an
empty plasmid (pL4440), we were able
to decrease ubh-4 mRNA levels by 20%,which is comparable to the level observed in daf-2(e1370) mu-
tants (Figures 5C and 5D). Furthermore, diluted ubh-4 RNAi
reduced the expression of UBH-4::GFP mainly in the intestine,
whereas undiluted ubh-4 RNAi resulted in an almost total loss
of UBH-4::GFP in all tissues (Figure 5E). Thus, experiments
with diluted ubh-4 RNAi provide an opportunity to investigate
proteasome function under similar ubh-4 expression conditions
as in the long-lived daf-2(e1370) animals.
UBH-4 Regulates Proteasome Activity
As the long-lived daf-2(e1370) mutants have less UBH-4 and
higher proteasome activity, we hypothesized that UBH-4 could
function as a proteasome inhibitor. It has been previously shown
that the human ortholog UCHL5 delays degradation of lightly
polyubiquitinated substrates (Lam et al., 1997b) and that knock-
down of uchl5 in HeLa cells leads to faster degradation of the
UPS reporter protein Ub-R-GFP, as well as to a reduced amount
of polyubiquitinated proteins (Koulich et al., 2008). In addition, it
has been reported that another proteasome-associated DUB
USP14 and its yeast homolog Ubp6 attenuate proteasomal
degradation (Hanna et al., 2006; Lee et al., 2010). To address
if UBH-4 regulates proteasome activity in C. elegans, we inves-
tigated how downregulation of ubh-4 by RNAi affected UPS ac-
tivity in different tissues. Excitingly, both undiluted and diluted
ubh-4 RNAi treatment resulted in higher UPS activity in the5, June 27, 2013 ª2013 The Authors 1985
Figure 5. Expression of ubh-4 Is Regulated in a DAF-16-Dependent Manner
(A) Expression of Pubh-4::gfp reporter in wild-type and IIS mutants. i, intestine; n, nerve ring; p, pharynx; g, gonad; e, embryo; m, muscle; s, spermatheca. The
exposure time varies between strains.
(B) Expression of Pubh-4(D531-525+6bp)::gfp reporter in daf-2(e1370) animals. Arrows point intestinal expression.
(legend continued on next page)
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intestine (Figures 6A and S5A). Accordingly, ubh-4 RNAi treat-
ments decreased the polyubiquitin reporter signal in the intestine
by 0.15- to 0.18-fold (Figure 6C). The enhanced proteasome ac-
tivity detected in the intestine after ubh-4 RNAi is interesting
considering that we observed accumulation of polyubiquitinated
proteins in whole-animal extracts after the same treatment. This
could be due to the accumulation of polyubiquitinated proteins in
other tissues, because inmuscle cells diluted ubh-4RNAi did not
affect UPS activity, and undiluted ubh-4 RNAi even caused
decreased reporter degradation compared to control RNAi ani-
mals (Figures 6B and S5B). The decreased UPS activity detected
in body-wall muscle cells after undiluted ubh-4 RNAi could stem
from a starting decline in general physiology, as the animals
looked sick when undergoing these imaging experiments. On
the whole-animal level, ubh-4 RNAi treatments increased
proteasome activity by 1.5- to 1.7-fold, as measured with pro-
teasome in-gel activity assay in RNAi-sensitive rrf-3(pk1426) an-
imals (Figures 6D and 6E). N2 animals displayed a similar trend in
upregulation of proteasome activity after ubh-4 RNAi (Fig-
ure S5C), but the effect was milder, which is probably due to
the lower RNAi efficacy. The increase in proteasome activity
detected in the in-gel assay after ubh-4 knockdown did not orig-
inate from general 19S disruption, because the proteasome
complexes were intact (Figure 6D) and disruption of the 19S by
RPN-2 RNAi resulted in decreased proteasome activity (Figures
S5D and S5E). In addition, ubh-4 knockdown did not affect the
levels of proteasome 20S alpha subunits (Figures S5F and
S5G), revealing that UBH-4 directly regulates proteasome activ-
ity and not abundance.
UBH-4 Slightly Affects Lifespan and Brood Size in
C. elegans
Because ubh-4 knockdown resulted in enhanced proteasome
activity, we investigated whether it also causes phenotypic ef-
fects such as changes in lifespan and fertility. A systematic
RNAi screen previously reported that ubh-4 RNAi slightly in-
creases lifespan (Hamilton et al., 2005). When we performed ex-
periments with undiluted ubh-4RNAi started from the L1 stage in
RNAi-sensitive rrf-3(pk1426) animals, we did not detect an in-
crease in lifespan, but instead consistently observed a minor
decrease (Table S4). However, by using diluted ubh-4 RNAi, a
slight but significant increase in lifespanwas detected (Figure 6F;
Table S4). Similar to the lifespan of rrf-3(pk1426) animals, the life-
span of daf-16(mgDf47);rrf-3(pk1426)mutants was shortened by
undiluted ubh-4RNAi, but no major changes were detected after
diluted ubh-4 RNAi treatment (Figure 6F; Table S4). The lifespan
of long-lived rrf-3(pk1426);daf-2(e1370) mutants was not
affected by either of the ubh-4 RNAi treatments (Figure 6F; Table
S4), indicating that a further decrease in the ubh-4mRNA level in
daf-2mutants does not provide beneficial effects on longevity. In
support of our lifespan analysis, mortality calculation revealed(C) Expression of ubh-4 in wild-type and IIS mutants examined with qPCR. Graph
type (set as 1). Results are averaged from three independent experiments. Error
(D) Expression of ubh-4 in rrf-3(pk1426) animals examined with qPCR after diluted
in ubh-4 mRNA levels compared to the control RNAi (set as 1). Results are avera
(E) Expression of Pubh-4::ubh-4::gfp in rrf-3(pk1426) animals after diluted (1%) a
See also Figures S3 and S4.
Cthat diluted ubh-4 RNAi decreased mortality of rrf-3(pk1426)
animals (Figure 6G), but did not affect mortality of long-lived
rrf-3(pk1426);daf-2(e1370) or short-lived daf-16(mgDf47);rrf-
3(pk1426) mutants (Figure S6A). Knockdown of ubh-4 by intes-
tine- or muscle-specific ubh-4 RNAi did not reproduce the
lifespan effect in animals with normal IIS (data not shown), indi-
cating that some additional tissue(s) including the intestine is
required for the ubh-4-mediated lifespan extension. Importantly,
ectopic expression of ubh-4 from an intestinal promoter, which
does not contain a canonical DAF-16 binding site, resulted in mi-
nor decrease in lifespan and increased mortality of daf-2(e1370)
mutants when compared to control animals expressing intestinal
Dendra2 (Figures 6H and 6I; Table S4).
We next tested whether ubh-4 RNAi affects brood size. We
detected decreased brood size in rrf-3(pk1426) animals after un-
diluted ubh-4RNAi (Figure S6B; Table S5), which is in line with an
earlier study reporting that ubh-4 RNAi causes embryonic
lethality (Maeda et al., 2001). However, diluted ubh-4 RNAi
did not significantly decrease brood size (Figure S6B; Table
S5). Brood sizes of rrf-3(pk1426);daf-2(e1370) or daf-
16(mgDf47);rrf-3(pk1426) mutants were not affected by ubh-4
RNAi treatments (Figure S6B; Table S5). Together, our data sug-
gest that ubh-4 is one of themany DAF-16 target genes affecting
cumulatively longevity, and that there might be a threshold in the
UBH-4 level for the beneficial effects on lifespan without
affecting other physiological processes, such as reproduction.
ubh-4RNAiDoesNot InduceDAF-16 or SKN-1Activation
To investigate whether the ubh-4 RNAi-induced enhancements
of proteasome activity and lifespan were derived from DAF-16-
mediated effects, we measured the expression of selected
DAF-16 target genes by qPCR after undiluted or diluted ubh-4
RNAi treatments. Although we noticed some fluctuation in
mRNA levels after ubh-4 RNAi, no major changes in expression
of DAF-16 target genes were observed (Figure S6C).
Next, we studied the effects of ubh-4 RNAi on expression of
SKN-1 target genes, as SKN-1, like DAF-16, is an IIS-regulated
transcription factor that promotes longevity and stress re-
sponses (Tullet et al., 2008). ubh-4 RNAi has been reported to
induce SKN-1::GFP translocation into the nuclei (Kahn et al.,
2008). When we performed ubh-4 RNAi experiments, no major
changes in the expression of the selected SKN-1 target genes
were detected (Figure S6D). Together, our data show that the in-
creases in longevity and proteasome activity caused by ubh-4
knockdown do not likely originate from activation of DAF-16 or
SKN-1.
Recent reports have demonstrated that increased expression
of a 19S subunit encoding gene rpn-6.1 and its human homolog
PSMD11 are required for enhanced proteasome activity in germ-
line-deficient C. elegans and human embryonic stem cells,
respectively (Vilchez et al., 2012a, 2012b). To test whether theshows the average fold changes in ubh-4mRNA levels compared to the wild-
bars, SD.
(1%) and undiluted ubh-4 knockdown. Graph shows the average fold changes
ge from four independent experiments. Error bars, SD.
nd undiluted ubh-4 RNAi. Arrows point intestinal expression.
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Figure 6. UBH-4 Regulates Proteasome Activity and Affects Lifespan
(A and B) (A) Quantified degradation of UbG76V-Dendra2 in intestinal cells and (B) in body-wall muscle cells of wild-type animals after control, diluted (1%), or
undiluted ubh-4 RNAi. Graphs in (A) and (B) show the average percentage of green or red fluorescence relative to the initial fluorescence intensity (before
photoconversion) or the intensity at the point of photoconversion (0 hr after conversion), respectively. Error bars, SEM, **p < 0.01, Table S2.
(C) Quantification of fluorescent intensity of intestinal polyubiquitin reporter in wild-type animals treated with control, diluted, or undiluted ubh-4 RNAi. Graph
shows average fold change in fluorescence compared to the control RNAi (set as 1). Error bars, SEM, **p < 0.01, Table S2.
(legend continued on next page)
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rpn-6.1 expression levels could be involved in the detected in-
creases in proteasome activity reported within this study, we
examined rpn-6.1 expression in wild-type and daf-2(e1370) ani-
mals, as well as in ubh-4 RNAi-treated animals. However, daf-
2(e1370) animals and ubh-4 RNAi-treated animals did not
display an increase in rpn-6.1 expression (Figures S6E and
S6F), demonstrating that the upregulation of proteasome activity
caused by reduced IIS or ubh-4 knockdown is not mediated by
changes in rpn-6.1 expression.
uchl5 Knockdown Increases the Degradation of the
Aggregation-Prone Ataxin3 Mutant
To examine if the regulation of ubh-4 by the IIS pathway is evolu-
tionarily conserved, we examined the expression of uchl5 in hu-
man osteosarcoma (U-2OS) cells under conditions of decreased
IIS. By treating the cells with the PI(3)K inhibitor LY-294002, we
detected approximately 30% decrease in uchl5 mRNA levels
as measured with qPCR (Figure 7A), indicating that human
uchl5 is also regulated by the IIS pathway. Next, we addressed
whether UCHL5 affects proteasome activity. Knockdown of
uchl5 (Figure S7A) slightly increased degradation of UbG76V-
GFP in U-2 OS cells (Figure 7B; Table S6) without decreasing
the level of the control GFP (data not shown). This result is in
agreement with a previous report showing that uchl5 small inter-
fering RNA (siRNA) increases UPS activity in HeLa cells (Koulich
et al., 2008).
Previously, it has been shown that the proteasome-associ-
ated DUB USP14 prevents degradation of several proteins
that cause neurotoxicity (Lee et al., 2010). We investigated if
uchl5 knockdown can also affect the levels and aggregation
of the neurotoxic protein ataxin3, which is known to undergo
proteasomal degradation. For this purpose, we expressed
ataxin3(Q28)-GFP and ataxin3(Q84)-GFP (Chai et al., 2002)
and knocked down uchl5 in U-2 OS cells. To analyze the micro-
scopy images of the transfected cells, we developed a method
to measure cellular fluorescence intensities (representing pro-
tein levels), number of fluorescent foci (representing possible
aggregates) and intensity of the foci (Figure S7B; Table S6;
Experimental Procedures). uchl5 siRNA decreased the fluores-
cent signal in both ataxin3(Q28)-GFP- and ataxin3(Q84)-GFP-
transfected cells, indicating that degradation of the transfected
proteins was increased (Figure 7C; Table S6). We also detected
a slight decrease in the number and a clear decrease in the in-
tensity of the fluorescent foci in ataxin3-GFP-transfected cells
after uchl5 siRNA (Figure S7C; Table S6), implying that
decreased levels of the transfected proteins affect the forma-(D) Lysates of rrf-3(pk1426) animals treated with control or ubh-4 RNAi separated
suc-LLVY-AMC substrate. Lower panel shows Coomassie staining of the gel.
(E) Quantification of proteasome in-gel activity from rrf-3(pk1426) animals treated
change compared to the control RNAi (set as 1). Results are mean of quantifica
experiments). Error bars, SEM.
(F) Kaplan-Meier survival analysis of rrf-3(pk1426), rrf-3(pk1426);daf-2(e1370) and
RNAi started from the L1 stage (log-rank test, ***p < 0.0001, Table S4).
(G) Mortality of rrf-3(pk1426) animals treated with control or diluted (1%) ubh-4 R
(H) Kaplan-Meier survival analysis of daf-2(e1370) mutants with intestinal ubh-4
(I) Mortality of daf-2(e1370)mutants with intestinal ubh-4 overexpression (ubh-4O
the same as in (H), Table S4.
See also Figure S6.
Ction of aggregates. Together, these results show that, similar
to the IIS-regulated UBH-4 in C. elegans (Figure 7D), a
decreased level of UCHL5 increases UPS activity and en-
hances degradation of aggregation prone proteins in human
cells.
DISCUSSION
The data we present establish an in vivo mechanism by which IIS
regulates proteasome activity through the FOXO transcription
factor DAF-16 target ubh-4. Together with Dr. Blackwell’s group,
we have previously shown that the IIS is involved in regulating
proteasome activity through the transcription factor SKN-1 in
C. elegans (Li et al., 2011). Studies by other groups have also re-
ported links between UPS and IIS by showing that FOXO tran-
scription factors regulate the expression of ubiquitin ligases
MAFbx and MuRF1, which contribute to muscle atrophy (Sandri
et al., 2004; Stitt et al., 2004). Recent studies have also
highlighted the roles of DAF-16 and FOXO4 in regulation of pro-
teasome activity in germline-lacking C. elegans and human em-
bryonic stem cells, respectively (Vilchez et al., 2012a, 2012b). In
addition, DAF-16 and possibly some other IIS components are
under proteasomal control, which affects lifespan in C. elegans
(Kuhlbrodt et al., 2011; Li et al., 2007). Here, we have identified
the DUB ubh-4 as differentially expressed in wild-type and
long-lived daf-2 IIS mutants.
The increase in UbG76V-Dendra2 degradation and decrease
in accumulation of polyubiquitinated proteins in the intestine,
which we observed upon ubh-4 RNAi, may stem from reduced
ubiquitin chain trimming by UBH-4. In accordance, previous
studies have demonstrated that proteasomal degradation of
ubiquitinated substrates can be enhanced by deleting or inhibit-
ing the ubiquitin-chain-trimming DUBs UCHL5 (UBH-4 ortholog)
or USP14 (Koulich et al., 2008; Lam et al., 1997a, 1997b; Lee
et al., 2010). It is likely that UBH-4 also regulates proteasome ac-
tivity in a noncatalytic manner, perhaps by inhibiting substrate
entry to the proteolytic core, as we observed that ubh-4 knock-
down increases proteasome activity also in the ubiquitination in-
dependent in-gel activity assay. Interestingly, the yeast homolog
of USP14, Ubp6, has been shown to inhibit substrate degrada-
tion in a manner independent of its deubiquitinating activity
(Hanna et al., 2006). On the other hand, binding of polyubiquiti-
nated proteins to USP-14 and UCHL5 can also activate protea-
somal ATPases (Peth et al., 2013). Thus, proteasome-associated
DUBs appear to exert their regulatory effects through multiple
mechanisms.on a native gel followed by in-gel proteasome activity assay with fluorogenic
with control, diluted or undiluted ubh-4 RNAi. Graph shows the average fold
tions (control and ubh-4 RNAi n = 15, diluted ubh-4 RNAi n = 10 independent
daf-16(mgDf47);rrf-3(pk1426) animals treatedwith control or diluted (1%) ubh-4
NAi. Data used for analysis are the same as in (F).
overexpression (ubh-4 OE) (log-rank test, *p < 0.05, Table S4).
E) and control animals expressing intestinal Dendra2. Data used for analysis are
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Figure 7. uchl5 siRNA Increases UPS Activ-
ity and Degradation of Proteins Linked to
Proteotoxicity in Human Cells
(A) Expression of uchl5 in U-2 OS cells after PI(3)K
inhibitor LY-294002 treatment (20 mM, 7 hr)
examined with qPCR. Graph shows the average
fold change in uchl5mRNA levels compared to the
DMSO-treated control (set as 1). Results are
average from three independent experiments. Er-
ror bar, SD.
(B) Violin plots showing mean cell fluorescence
intensity in U-2 OS cells transfected with vector
encoding UbG76V-GFP and control or uchl5
siRNA and (C) with vectors encoding ataxin3(Q28)-
GFP or ataxin3(Q84)-GFP and control or uchl5
siRNA (***p < 0.001, Table S6).
(D) A model for IIS-regulated proteasome activity.
Decreased IIS mediated by daf-2 mutation acti-
vates DAF-16 resulting in downregulation of ubh-4
expression, which, in turn, upregulates protea-
some activity.
See also Figure S7.Surprisingly, we detected increased accumulation of polyubi-
quitinated proteins in whole-animal extracts after ubh-4 RNAi,
although proteasome activity increased according to the in-gel
proteasome activity assay and the intestinal fluorescent re-
porters. This could be a consequence of proteasome inhibition
in other tissues, such as body-wall muscle, in which we detected
decreased proteasome activity after ubh-4 RNAi. The tissue-
specific effects of ubh-4 knockdown could derive from variable
expression levels of ubh-4 between tissues, but also from differ-
ential expression of, for example, the proteasomal polyubiquitin
receptor rpn-13. In mammalian cells, association of UCHL5 with
RPN13 has been reported to activate UCHL5 (Yao et al., 2006).
Alternatively, UBH-4 might possess the same function as1990 Cell Reports 3, 1980–1995, June 27, 2013 ª2013 The AuthorsUCHL5 in rescuing poorly ubiquitinated
substrates from degradation (Lam et al.,
1997b). In this scenario, deubiquitination
leads to substrate dissociation from the
proteasome. Therefore, in our case,
knockdown of ubiquitin-chain-trimming
UBH-4 may lead to preferred and faster
degradation of lightly ubiquitinated sub-
strates and to the accumulation of heavily
polyubiquitinated proteins, which can
then be detected in the polyubiquitin
western blot.
We have previously shown that the IIS-
regulated SKN-1 affects proteasome ac-
tivity mainly in the intestine (Li et al.,
2011). The role of DAF-16 as a protea-
some activity modulator through UBH-4
is also most prominent in the intestine,
where ubh-4 expression is downregu-
lated in a DAF-16-dependent manner.
Recent reports suggest a high degree of
complexity in regulation of DAF-16-medi-ated processes with different isoforms crosstalking, regulating
partly distinct sets of genes, and showing tissue specificity
(Kwon et al., 2010). Additionally, the growth factor IGF-1, which
inhibits FOXO activity, increases proteasome activity in mouse
brain frontal cortex lysates (Crowe et al., 2009), whereas overex-
pression of constitutively active FOXO3 slightly increases pro-
teasomal degradation in myotubes (Zhao et al., 2007). Together
with these reports, our results establish that proteasome activity
is under cell-type-specific regulation by the IIS.
Enhancement of proteasome activity has been shown to
extend lifespan in yeast and Drosophila (Kruegel et al., 2011;
Tonoki et al., 2009), and high proteasome activity has been
observed in lysates from long-lived naked mole-rats and
fibroblasts derived from centenarians (Chondrogianni et al.,
2000; Pe´rez et al., 2009). Additionally, a recent study reported
that ectopic expression of rpn-6 in C. elegans resulted in upre-
gulated proteasome activity and extended lifespan during mild
heat stress (Vilchez et al., 2012b). We suggest that the mild ef-
fect of UBH-4 on C. elegans lifespan could derive from its
regulation of proteasome activity. The minor lifespan effect of
ubh-4 downregulation is in agreement with the cooperative ac-
tion of the DAF-16 target genes on longevity (Kenyon, 2010).
Because both activation of the proteasome and the slight in-
crease in lifespan are attained after an approximate 20%
decrease in total ubh-4 mRNA, we speculate that a subpopu-
lation of proteasome complexes is lacking the associated
UBH-4. Under these conditions, the proteasome-associated
deubiquitinating activity would not be downregulated to an
extent causing negative physiological effects, emphasizing
the fine balance in gene expression required to control cellular
processes.
In addition to our results showing that the IIS/DAF-16 pathway
regulates proteasome activity, epidermal growth factor signaling
has been reported to affect proteasomal degradation and
longevity (Liu et al., 2011). Modulation of proteasome activity
through multiple lifespan regulating pathways would provide
flexibility in meeting the proteostasis requirements upon aging.
Similar to many of the cellular processes in metazoans, we
show that the enhancement of proteasome activity through
downregulation of ubh-4 is evolutionarily conserved. Affecting
the IIS in a cell-type-specific manner could create opportunities




C. elegans strains were grown under standard conditions (Brenner, 1974) at
20C. N2 (Bristol) strain was used as the wild-type. N2, CB1370: daf-
2(e1370)III, DR26: daf-16(m26)I, GR1307: daf-16(mgDf50)I, DR1309: daf-
16(m26)I;daf-2(e1370)II, GR1309: daf-16(mgDf47)I;daf-2(e1370)III, CF1814:
rrf-3(pk1426)II;daf-2(e1370)III, IU10: daf-16(mgDf47)I;rrf-3(pk1426)II, NR350:
rde-1(ne219)V;kzIs20, and VP303: rde-1(ne213)V;kbIs7 were obtained from
the Caenorhabditis Genetics Center (CGC). NL2099: rrf-3(pk1426)II mutant
strain was a generous gift from Dr. G. Wong (University of Eastern Finland).
Transgenic lines used in this study are listed in Table S1.
Lifespan Assays and Progeny Counts
All lifespan experiments were performed at 20C. Synchronized animals were
plated on RNAi feeding plates as L1 larvae (day 1). Animals were transferred
to a new plate every second day and, once they stopped producing offspring,
every few days. Animals were checked every day and classified as dead when
they failed to respond to agentle prodwitha platinumpick. Animals that crawled
off the plate, died from an extruded gonad or had internally hatched offspring
were censored at the time of their death. Each survival assay was repeated
two to five times. For progeny counts, synchronized animals were plated on
RNAi feedingplatesasL1 larvae.Animalsweremoved to freshRNAiplatesevery
dayuntil they stoppedproducing offspring. Total viable offspringper animalwas
counted. The offspring of animals that crawled off the plate died of internally
hatched offspring or an extruded gonad before having stopped laying eggs
were censored. Experiments were repeated three to five times.
Plasmids and Generation of Transgenic Lines
Cloning of Dendra2 and UbG76V-Dendra2 expression vectors has been
described earlier (Hamer et al., 2010; Li et al., 2011). pPubh-4::gfp expressionCvector was created by amplifying 1375 bp promoter region upstream and
264 bp downstream of the ubh-4 coding region using PCR (see Table S7 for
all primers used for cloning in this study). The PCR product amplified upstream
of ubh-4 coding region was digested with PciI and AgeI, and the downstream
amplified PCR product was digested with NotI. Sequences were cloned into
the pPD30.38 expression vector containing GFP coding sequence cloned be-
tween inserted AgeI and NotI restriction sites (the unc-54 promoter and
enhancer were replaced).
To create the pPubh-4(D531-525+6bp)::gfp expression vector, the pPubh-
4::gfp expression vector was amplified with PCR using oligonucleotides hav-
ing SmaI restriction site in place of DAF-16 consensus sequence (gtaaaca).
To create the pPubh-4::ubh-4::gfp expression vector, the ubh-4 coding region
amplified with PCR from C. elegans cDNA was digested with AgeI and cloned
into the pPubh-4::gfp expression vector.
To create pPubh-4::His-gfp expression vector, the sequence encoding
His-SBP tag was amplified with PCR (from Gateway Drosophila expression
vector, kind gift of Dr. Jussi Taipale), digested with AgeI, and inserted in
front of the GFP sequence in pPubh-4::gfp expression vector. For pPubh-
4::His-ubh-4-gfp expression vector, GFP was replaced between NheI and
AgeI sites with ubh-4 coding region amplified with PCR from C. elegans
cDNA. Expression vector pPrpn-13::HA-RPN-13 was created by amplifying
with PCR 1,100 bp promoter sequence upstream of rpn-13 coding region.
The PCR product was digested with EcoRV and AgeI and ligated into PciI
(blunted with Klenow fragment) and AgeI-digested pPubh-4::gfp expression
vector to replace ubh-4 promoter. GFP was replaced with rpn-13 coding re-
gion, which was amplified with PCR from C. elegans cDNA. PCR product
was digested with AgeI and Acc65I. The sequence encoding HA tag was
amplified with PCR (from Gateway Drosophila expression vector, kind gift
of Dr. Jussi Taipale), and the product was digested with AgeI and ligated
in front of the rpn-13 coding sequence. To create vector for intestinal ubh-
4 overexpression (pPvha-6::ubh-4), the ubh-4 coding region, amplified with
PCR from C. elegans cDNA (digested with AgeI and NheI and blunted
with Klenow fragment), was used to replace the ZsGreen coding sequence
in NheI- and NotI-digested, Klenow-fragment-blunted pPvha-6::ZsGreen
expression vector (not used in this study). All transgenic lines were created
by microinjection (Mello et al., 1991). Of the strains carrying extrachromo-
somal arrays, four independent lines expressing transcriptional- or
translational ubh-4 reporters, two independent lines of Dendra2 or
UbG76V-Dendra2 transgenic strains, and one line of both strains used in
immunoprecipitation experiments were isolated and analyzed. Results
shown are representative of all lines.
To create ZsProSensor expression vector for intestinal cells, ZsProSensor
coding sequence was cut from pZsProSensor-1 vector (Clontech) with NheI
and NotI and ligated into the NheI- and NotI-digested pPD30.38 expression
vector (Addgene, Fire Lab vector kit) containing unc-54 promoter. To create
polyubiquitin reporter (UIM2-ZsProSensor) expression constructs for in-
testinal cells, ZsGreen-MODC coding sequence was amplified with PCR
from pZsProSensor-1 vector (Clontech). PCR product was digested with
AgeI and NotI. Coding sequence for polyubiquitin binding motifs (UIMs, amino
acids 195–313) of the RPN-10 was amplified with PCR from C. elegans cDNA,
and the product was digested with NheI and AgeI. PCR fragments were ligated
into the NheI- and NotI-digested pPD30.38 expression vector containing unc-
54 promoter. The vha-6 promoter was amplified with PCR from Pvha-6::HSF-1
expression vector (Morley and Morimoto, 2004) (kind gift of Dr. Richard Mor-
imoto). The PCR product was digested with PciI and NheI and used to replace
unc-54 promoter in both ZsProSensor and polyubiquitin reporter expression
vectors. The Polyubiquitin reporter extrachromosomal array was integrated
using gamma irradiation and backcrossed five times with wild-type. One line
carrying integrated transgene was used in experiments. The integrated line
carrying polyubiquitin reporter transgene in daf-2(e1370) background was
created by crossing.
For mammalian cell culture experiments, expression vectors pEGFP-C1-
Ataxin3Q28 (Addgene plasmid 22122), pEGFP-C1-Ataxin3Q84 (Addgene
plasmid 22123) (Chai et al., 2002), and UbG76V-GFP (Addgene plasmid
11941) (Dantuma et al., 2000) were purchased from Addgene. pEGFP-C2
expression vector (kind gift of Dr. Marikki Laiho) was used to express GFP in
mammalian cells.ell Reports 3, 1980–1995, June 27, 2013 ª2013 The Authors 1991
Mammalian Cell Culturing
Human osteosarcoma (U-2 OS) cells were cultured in Dulbecco’smodified Ea-
gle’s medium with 15% fetal bovine serum (GIBCO). For siRNA experiments,
FlexiTube GeneSolution for uchl5 (QIAGEN) and AllStars Negative Control
siRNA (QIAGEN) were used with HiPerFect Transfection Reagent (QIAGEN).
Cells were incubated for 3 days with medium containing siRNAs. Expression
vectors for ataxin3(Q28), ataxin3(Q84), and UbG76V-GFP were transfected
with Fugene 6 (Roche) a day after siRNA transfection. Cells were fixed with
3.5% paraformaldehyde in PBS. For PI(3)K inhibition, U-2 OS cells were incu-
bated for 7 hr with 20 mM LY-294002 (Enzo Life Sciences).
C. elegans RNA Interference
Unless otherwise indicated, RNAi was performed using the feeding protocol as
described earlier (Timmons et al., 2001). E. coli strain HT115 carrying the
empty pL4440 expression vector was used as a control in experiments with
RNAi clones from J. Ahringer library. daf-2(e1370) mutants carrying intestinal
UbG76V-Dendra2 were placed on rpn-2 RNAi (C23G10.4, J. Ahringer library)
as L3 larvae 2 days before photoconversion. For proteasome in-gel activity as-
says, rrf-3(pk1426) animals were placed on rpn-2 RNAi as L4 larvae and har-
vested 2 days later. Animals expressing polyubiquitin reporter in the intestine
were maintained on control RNAi bacteria and transferred to rpn-2 RNAi at L4
larvae and imaged 3 days later. Bacteria carrying empty RNAi vector (pL4440)
was used to dilute ubh-4 RNAi bacteria. In imaging experiments, ubh-4 and
lgg-1 (C08B11.7 andC32D5.9, respectively, J. Ahringer library) RNAi were initi-
ated from hatching. ubh-4 RNAi was initiated from L1 stage in proteasome in-
gel activity assays, lifespan experiments, and progeny counts. For daf-16RNAi
(pAD43) and pAD12 (control RNAi for daf-16) (kind gifts of Dr. Andrew Dillin),
10 mM isopropyl b-D-1-thiogalactopyranoside (IPTG) was used to induce pro-
duction of double-stranded RNA, and, before seeding the plates, IPTG con-
centration was added to 20 mM. L4440-daf-16a (Addgene plasmid 31503)
and L4440-daf-16 df (Addgene plasmid 31505) RNAi expression vectors
(Kwon et al., 2010) were purchased from Addgene. daf-16 RNAi was initiated
from hatching in all experiments and imaged at first day of adulthood.
C. elegans Immunofluorescence
An unsynchronized population of animals expressing polyubiquitin reporter
was fixed and permeabilized as described previously (Finney and Ruvkun,
1990). Polyubiquitinated proteins were immunostained with FK1 antibody
(Enzo) and visualized with Alexa Fluor 594 (Invitrogen).
Microscopy, Image Analysis, Equipment, and Settings
For UbG76V-Dendra2 and Dendra2 imaging, young adult (4 and 5 days old
with transgenic animals in daf-2(e1370) background) animals were imaged.
Dendra2 imaging was done as described earlier (Hamer et al., 2010). Briefly,
animals were mounted on an agarose pad on glass slides and immobilized us-
ing 0.5 mM levamisole in M9 (22 mMKH2PO4, 41 mMNa2HPO4, 8.5 mMNaCl,
and 19 mM NH4Cl). Animals were recovered on feeding plates in between im-
aging steps. For confocal imaging, a motorized Zeiss Axio Observer Z1 in-
verted microscope with LSM 5 Live line scanner and LSM AIM software Rel.
4.2 was used. Images were acquired with 63 3 1.4 numerical aperture (NA)
plan-apochromat objective. Photoconversion was carried out using a diode
405 nm (50 mW). Diode-pumped solid-state (DPSS) (488 nm; 100 mW) and
561 nm DPSS (40 mW) lasers were used to visualize Dendra2 before and after
photoconversion. To facilitate image analysis, gain/laser power of the red
channel was adjusted to get approximately similar red fluorescence intensity
in each sample after photoconversion. Images were acquired at a depth of 8
bits per channel and 512 3 512 pixels (scanning speed 177.62 ms per pixel)
at a pixel resolution of 210 nm. Fluorescence intensities were analyzed with
Zeiss LSM Image Examiner version 4.2. To calculate the relative intensities,
the absolute values of fluorescence before and right after photoconversion
were set as 100% for the green and red fluorescence signals, respectively.
Fluorescence images are pseudocolored using Zeiss LSM Image Examiner
version 4.2.
Polyubiquitin reporter animals treated with ubh-4 or rpn-2 RNAi were
imaged at 6 days old or as young adults (4 and 5 days old with transgenic an-
imals in daf-2[e1370] background) after daf-16 RNAi. Animals carrying Pubh-
4::gfp or Pubh-4(D531-525+6bp)::gfp transcriptional or Pubh-4::ubh-4::gfp1992 Cell Reports 3, 1980–1995, June 27, 2013 ª2013 The Authorstranslational reporter were imaged as young adults (4 and 5 days old with
transgenic animals in daf-2(e1370) background). Polyubiquitin reporter,
Pubh-4::gfp, and Pubh-4(D531-525+6bp)::gfp transcriptional and Pubh-
4::ubh-4::gfp translational reporter animals were imaged with a Zeiss Axioplan
2 microscope using 103 0.3 NA objective. Fluorescence signal intensity from
the intestine of polyubiquitin reporter animals was quantifiedwith Fiji. Confocal
images of the FK1 immunostained polyubiquitin reporter animals were taken
by using a motorized Zeiss AxioVert 200 M inverted microscope with LSM
510 point scanner and LSM software release 3.2. Images were acquired
with 63 3 1.4 NA plan-apochromat objective, and 488 nm argon (30 mW)
and 543 nm helium-neon (1 mW) lasers.
U-2 OS cells transfected with uchl5 siRNA and constructs expressing GFP
and wild-type or mutant ataxin3 were imaged with Zeiss Axioplan 2 micro-
scope using 20 3 0.5 NA objective. Analysis of fluorescence intensities and
aggregate counts (with ataxin3) were made in a computational pipeline
created in the freely available Anduril analysis framework (Ovaska et al.,
2010). The pipeline begins with finding the cytoplasm based on the GFP chan-
nel. To aid the segmentation, nuclei fromHoechst channel were also detected.
The cell fluorescence intensity measurements were done based on the cyto-
plasm segmentation. Local maxima with radii of three and seven pixels were
detected in the GFP channel and joined together and grown to three pixel
radius disks. These points represent the aggregates in the signal, and thus
the aggregate-related measurements were done on the disk areas. U-2 OS
cells transfected with uchl5 siRNA and UbG76V-GFP were imaged with Zeiss
Axioplan 2 microscope using 10 3 0.3 NA objective. The cell fluorescence in-
tensity measurements were done as described above.
Quantitative Real-Time PCR
For RNA extraction from each strain or RNAi experiment, synchronized young
adult animals (4 and 5 days old with daf-2[e1370] strain) were harvested. Total
RNA was extracted using a NucleoSpin RNA II kit (Macherey-Nagel) or Gene-
Jet RNA Purification Kit (Fermentas). RT-PCR was done using a Maxima First
Strand cDNA Synthesis Kit for RT-qPCR (Fermentas). Quantitative real-time
PCR was done using Maxima SYBR Green/ROX qPCR Master Mix (23) (Fer-
mentas) and LightCycler 480 (Roche) quantitative PCR machine. ubh-4 and
rpn-6.1 qPCR data were normalized to the geometric mean of three reference
gene mRNA concentrations (act-1, cdc-42, and pmp-3) (Vandesompele et al.,
2002). DAF-16 and SKN-1 target gene qPCR data were normalized with act-1
mRNA concentrations, and qPCR data frommammalian cells were normalized
with gapdh mRNA concentrations. For qPCR oligonucleotide sequences, see
Table S7.
Native Gel Electrophoresis
Age-synchronized young adult animals (4 and 5 days old with daf-2[e1370]
strain) were collected to M9 prior to freezing in –80C. Animals were lysed us-
ing Dounce homogenizer and native gel lysis buffer (Elsasser et al., 2005).
Native gel electrophoresis and developing of the gel was performed like re-
ported earlier (Elsasser et al., 2005) with minor modifications. Gels were run
in ice bath for 3 or 6 hr using 40 or 20 mA as a constant, respectively. Devel-
oping buffer with 80 mM of suc-LLVY-AMC (Bachem) was used to develop
the gel. Coomassie staining was done with Colloidal Blue Staining Kit (Invitro-
gen). For deubiquitinating assay on native gel, electrophoresis was done like
described above. Development of the gel was done in developing buffer
(Elsasser et al., 2005) supplied with 1 mM Ub-AMC (Boston Biochem) for
1 hr at 30C. Gels were imaged with MultiImage Light Cabinet using Fluo-
rChem (3.04B) program (Alpha Innotech Corporation). Signal levels were
adjusted using Photoshop 9.0 (Adobe Systems) and quantified analyzed using
Fiji. The quantification of the proteasome activity is the sum of fluorescent
signal within the bands representing RP2-CP, RP-CP, and CP. As a technical
point, we noticed that the proteasome activity measurements using the in-gel
activity assay produce sometimes inconsistent results, and therefore multiple
repeats were performed.
Mass Spectrometry Analysis
The proteins were separated using native gel and visualized with Coomassie
staining. For protein identification, gel lanes containing RP2-CP and RP-CP
proteasome complexes were extracted followed by in-gel trypsin digestion.
Peptides were analyzed by liquid chromatography tandem mass spectrom-
etry (LC-MS/MS) using an Ultimate 3000 nano-LC (Dionex) and a QSTAR
Elite hybrid quadrupole TOF-MS (Applied Biosystems/MDS Sciex) with
nano-ESI ionization as described previously (Ohman et al., 2010). The LC-
MS/MS data were searched with in-house Mascot version 2.2 through
ProteinPilot 3.0 interface against the NCBInr 20100513 database
(10,987,230 sequences; 3,739,173,051 residues, taxonomy: C. elegans
[28,762 sequences]). All of the reported protein identifications are statistically
significant (p < 0.05).
Immunoprecipitation and Western Blotting
His-tag immunoprecipitation was done with Protino Ni-NTA agarose
(Macherey-Nagel). Western blot samples were separated on a polyacrylamide
gel and blotted onto a nitrocellulose membrane using a semidry blotting sys-
tem (Bio-Rad). FK1 antibody for polyubiquitinated proteins (Enzoproteasome
20S a1, 2, 3, 5, 6, and 7 subunits antibody (Enzo), anti-a-tubulin antibody
(Sigma), streptavidin-HRP (Dako), and anti-HA antibody (Covance) were
used in blotting. Signal levels were adjusted using Photoshop 9.0 (Adobe Sys-
tems) and quantified using Fiji.
Statistical Analysis
With Dendra2 and polyubiquitin reporter imaging, the statistical difference of
relative protein degradation between different strains or RNAi treatments
was determined by applying the Student’s t test (two-tailed). Lifespan
statistics were performed on R, with Kaplan-Meier survival plot and
stratified log-rank test (Mantel-Cox). Mortality was calculated by using ln
[ln(px)] formula (where px is survival probability at day x to x + 1).With progeny
counts, the statistical difference between different RNAi treatments was
determined by applying the Student’s t test (two-tailed). Statistical analysis
of mammalian cell image data was performed by applying Student’s t test
(two-tailed).
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